AQR Capital Management - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 65 filers reported holding OVID THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$1,180,000
+140.3%
301,767
+147.2%
0.00%
+100.0%
Q1 2021$491,000
+601.4%
122,059
+301.7%
0.00%
Q4 2020$70,000
-75.9%
30,387
-40.0%
0.00%
Q3 2020$291,00050,6340.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,006,185$12,860,0005.90%
GLOBEFLEX CAPITAL L P 2,794,834$8,972,0000.92%
BVF INC/IL 6,631,051$21,286,0000.77%
EcoR1 Capital, LLC 6,082,200$19,524,0000.62%
CHI Advisors LLC 400,000$1,284,0000.43%
Ikarian Capital, LLC 705,082$2,264,0000.34%
Artal Group S.A. 2,500,000$8,025,0000.22%
DCF Advisers, LLC 141,701$455,0000.18%
PLATINUM INVESTMENT MANAGEMENT LTD 766,901$2,462,0000.07%
ACADIAN ASSET MANAGEMENT LLC 2,040,084$6,543,0000.02%
View complete list of OVID THERAPEUTICS INC shareholders